H.R.3917 - Medicare Nuclear Medicine Payment Group Clarification Act of 2009
To amend title XVIII of the Social Security Act to modernize and improve the Medicare payment methodology for radiopharmaceuticals under the hospital outpatient prospective payment system and to ensure equitable payment and patient access to certain low volume, high cost radiopharmaceuticals.
One Moment Please
Loading Bill Text
Rollover any line of text to comment and/or link to it.
To amend title XVIII of the Social Security Act to modernize and improve the Medicare payment methodology for radiopharmaceuticals under the hospital outpatient prospective payment system and to ensure equitable payment and patient access to certain low volume, high cost radiopharmaceuticals.CommentsClose CommentsPermalink
Mr. STUPAK (for himself and Mr. PITTS) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concernedCommentsClose CommentsPermalink
To amend title XVIII of the Social Security Act to modernize and improve the Medicare payment methodology for radiopharmaceuticals under the hospital outpatient prospective payment system and to ensure equitable payment and patient access to certain low volume, high cost radiopharmaceuticals.CommentsClose CommentsPermalink
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,CommentsClose CommentsPermalink
SECTION 1. SHORT TITLE.
This Act may be cited as the ‘Medicare Nuclear Medicine Payment Group Clarification Act of 2009’.CommentsClose CommentsPermalink
SEC. 2. PAYMENT GROUP STANDARDS FOR NUCLEAR MEDICINE PROCEDURES AND RADIOPHARMACEUTICALS.
(a) In General- The last sentence of section 1833(t)(2) of the Social Security Act (42 U.S.C. 1395l(t)(2)) is amended--CommentsClose CommentsPermalink
(1) by inserting ‘, including for a nuclear medicine group the cost of any associated diagnostic radiopharmaceutical that is included in the payment for the service’ after ‘(or mean cost, if so elected) for an item or service within the group’; andCommentsClose CommentsPermalink
(2) by inserting ‘or in the case of services within a nuclear medicine group’ after ‘Federal Food, Drug and Cosmetic Act’.CommentsClose CommentsPermalink
(b) Effective Date- The amendments made by subsection (a) shall apply to items and services furnished on or after January 1, 2010.CommentsClose CommentsPermalink
OpenCongress is a free and open-source project of the Participatory Politics Foundation, a 501(c)3 non-profit organization with a mission to increase civic engagement. The non-profit Sunlight Foundation is the Founding and Primary Supporter of OpenCongress.
U.S. Congress - Text of H.R.3917 as Introduced in House Medicare Nuclear Medicine Payment Group Clarification Act of 2009
